US Stock MarketDetailed Quotes
PLXPQ PLx Pharma
- 0.000001
- 0.0000000.00%
15min DelayClose Oct 2 16:00 ET
29.14Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)29.14MShares0.00020052wk High0.00P/B25.25Float Cap0.00000152wk Low--Dividend TTM25.25MShs Float136.800000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
PLx Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -94.17%386K | 483K | 2.08M | 27,260.00%8.21M | 370,332.56%1.59M | 6.62M | 0 | 0 | -94.69%30K | -101.80%-430 |
| Operating revenue | -94.17%386K | --483K | --2.08M | 27,260.00%8.21M | 370,332.56%1.59M | --6.62M | --0 | --0 | -94.69%30K | -101.80%-430 |
| Cost of revenue | -62.69%1.46M | 820K | 1.17M | 4.81M | 892K | 3.91M | 0 | 0 | 0 | 0 |
| Gross profit | -139.73%-1.07M | -337K | 914K | 11,243.33%3.4M | 162,890.70%700K | 2.7M | 0 | 0 | 30K | -430 |
| Operating expense | -22.28%9.77M | 119.12%14.2M | 431.57%19.11M | 227.62%44.19M | 483.84%21.55M | 294.09%12.57M | 79.93%6.48M | 19.55%3.6M | -8.66%13.49M | -2.38%3.69M |
| Selling and administrative expenses | -16.99%9.14M | 148.18%13.65M | 600.15%18.46M | 337.28%40.01M | 745.19%20.86M | 455.92%11.01M | 149.10%5.5M | 5.73%2.64M | -8.74%9.15M | -13.26%2.47M |
| Research and development costs | -59.86%623K | -43.44%556K | -31.80%654K | -3.62%4.18M | -43.74%688K | 28.55%1.55M | -29.53%983K | 86.61%959K | -8.48%4.34M | 30.72%1.22M |
| Operating profit | -9.91%-10.84M | -124.32%-14.54M | -406.15%-18.2M | -203.07%-40.79M | -464.81%-20.85M | -209.31%-9.86M | -81.33%-6.48M | -19.65%-3.6M | 5.23%-13.46M | 1.75%-3.69M |
| Net non-operating interest income expense | 2,875.00%119K | 625.00%29K | 130.00%3K | 100.32%1K | 107.36%3K | 105.50%4K | 104.17%4K | 89.85%-10K | 47.77%-308K | 64.11%-40.79K |
| Total other finance cost | -2,875.00%-119K | -625.00%-29K | -130.00%-3K | -100.32%-1K | -107.36%-3K | -105.50%-4K | -104.17%-4K | --10K | --308K | --40.79K |
| Other net income (expense) | 118.86%2.22M | 126.44%2.65M | 193.36%7.41M | -269.53%-5.34M | 674.52%24.41M | -8,857.95%-11.78M | -419.90%-10.03M | -272.53%-7.94M | 74.71%-1.44M | -327.08%-4.25M |
| Gain on sale of security | 118.86%2.22M | 126.44%2.65M | 193.36%7.41M | -269.53%-5.34M | 674.52%24.41M | -8,857.95%-11.78M | -419.90%-10.03M | -272.53%-7.94M | 74.71%-1.44M | -327.08%-4.25M |
| Income before tax | 60.74%-8.5M | 28.16%-11.86M | 6.54%-10.79M | -203.23%-46.13M | 144.63%3.56M | -592.21%-21.64M | -194.79%-16.51M | -871.35%-11.54M | 25.81%-15.21M | -299.07%-7.98M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 60.74%-8.5M | 28.16%-11.86M | 6.54%-10.79M | -203.23%-46.13M | 144.63%3.56M | -592.21%-21.64M | -194.79%-16.51M | -871.35%-11.54M | 25.81%-15.21M | -299.07%-7.98M |
| Net income continuous Operations | 60.74%-8.5M | 28.16%-11.86M | 6.54%-10.79M | -203.23%-46.13M | 144.63%3.56M | -592.21%-21.64M | -194.79%-16.51M | -871.35%-11.54M | 25.81%-15.21M | -299.07%-7.98M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 60.74%-8.5M | 28.16%-11.86M | 6.54%-10.79M | -203.23%-46.13M | 144.63%3.56M | -592.21%-21.64M | -194.79%-16.51M | -871.35%-11.54M | 25.81%-15.21M | -299.07%-7.98M |
| Preferred stock dividends | 45.37%2.53M | 0 | 440.83%2.2M | 0.53%322K | -87.37%1.74M | 60.54%509.58K | ||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 60.74%-8.5M | 36.62%-11.86M | 9.08%-10.79M | -187.05%-48.65M | 141.95%3.56M | -496.81%-21.64M | -211.47%-18.71M | -1,802.94%-11.86M | 50.52%-16.95M | -266.40%-8.49M |
| Basic earnings per share | 62.50%-0.3 | 45.57%-0.43 | 46.58%-0.39 | -18.39%-2.06 | 111.49%0.1 | -100.00%-0.8 | -19.70%-0.79 | -1,012.50%-0.73 | 54.69%-1.74 | -248.00%-0.87 |
| Diluted earnings per share | 62.50%-0.3 | 45.57%-0.43 | 46.58%-0.39 | -18.39%-2.06 | 16.09%-0.73 | -100.00%-0.8 | -19.70%-0.79 | -1,012.50%-0.73 | 54.69%-1.74 | -248.00%-0.87 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg